Long COVID After Bamlanivimab Treatment
Teresa H. Evering(Cornell University), Asha Kallianpur(Cleveland Clinic Lerner College of Medicine), Kara W Chew, Nikolaus Jilg(Harvard University), William Murtaugh, Joseph J. Eron(University of North Carolina at Chapel Hill), Eunice Yeh(Cancer Research And Biostatistics), Carlee Moser(Harvard University), Nilam Patel, Paul Klekotka(Eli Lilly (United States)), Arzhang Cyrus Javan(National Institutes of Health), Jonathan Z. Li(Brigham and Women's Hospital), Howard Gutzman, Davey M. Smith(University of San Diego), Lara Hosey, Robert W. Coombs(University of Namur), David A. Wohl(University of North Carolina at Chapel Hill), Alexander L. Greninger(University of Washington), Erin A. Goecker, Glenda Daza(University of Washington), Grace M. Aldrovandi(Children's Hospital of Philadelphia), Jhoanna Roa, Busola Sanusi(Cancer Research And Biostatistics), Eric S. Daar(UCLA Medical Center), Judith S. Currier(University of California, Los Angeles), Emily Degli-Angeli(Cornell University), Michael D. Hughes(Virginia Tech), Rachel Bowman, Kevin Knowles, Stacey Adams, Lorraine Waring, Diane Hessinger, Bill Erhardt, Joan Dragavon, Marlene Cooper, Socorro Harb
Cited by 4
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k